Short Interest in Venus Concept Inc. (NASDAQ:VERO) Increases By 32.8%

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 33,600 shares, an increase of 32.8% from the February 28th total of 25,300 shares. Based on an average trading volume of 53,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 8.9% of the shares of the stock are short sold.

Venus Concept Stock Performance

Shares of Venus Concept stock opened at $2.62 on Wednesday. The company’s 50 day moving average price is $3.41 and its two-hundred day moving average price is $4.18. The firm has a market capitalization of $1.73 million, a P/E ratio of -0.33 and a beta of 0.52. Venus Concept has a fifty-two week low of $2.33 and a fifty-two week high of $17.49. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18.

Venus Concept (NASDAQ:VERO) last announced its quarterly earnings results on Monday, March 31st. The company reported ($11.23) EPS for the quarter, missing analysts’ consensus estimates of ($10.01) by ($1.22). The firm had revenue of $15.77 million during the quarter, compared to the consensus estimate of $16.99 million.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.